Heterogeneous lymphokine-activated killer cell precursor populations Bernard A. FoxSteven A. Rosenberg Original Articles Pages: 155 - 166
In vivo antitumor effect of methotrexate conjugated to a monoclonal IgM antibody specific for stage-specific embryonic antigen-1, on MH-15 mouse teratocarcinoma Stefano PersianiByron BallouThomas R. Hakala Original Articles Pages: 167 - 170
Monoclonal antibodies against epitopes on ganglioside GD2 and its lactones K. BossletH. D. MennelH. Wiegandt Original Articles Pages: 171 - 178
Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse Philip O. LivingstonGerd RitterMichele Jones Calves Original Articles Pages: 179 - 184
Blocked and not blocked whole-ricin-antibody immunotoxins: Intraperitoneal therapy of human tumour xenografted in nude mice P. BrusaF. PietribiasiL. Cattel Original Articles Pages: 185 - 192
Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-α against primary lung cancer targets Stephen C. YangLaurie Owen-SchaubJack A. Roth Original Articles Pages: 193 - 198
Implantation of a gelatin-sponge as a model for effector recruitment Emmanuel T. AkporiayeMuthulakshmi K. Kudalore Original Articles Pages: 199 - 204
Serological response of non-human primates to human melanoma disialoganglioside GD3 Gary M. StuhlmillerKathryn M. RobersonH. F. Seigler Original Articles Pages: 205 - 210
Corticosteroids inhibit the generation of lymphokine-activated killer activity in vitro Daniel W. McVicarRandall E. MerchantHarold F. Young Original Articles Pages: 211 - 218
Induction of nonspecific killer cells by delayed-type hypersensitivity against soluble protein antigens in murine peritoneal cavities Toshihiko TakaoYoshihiro MorikawaKoji Saito Original Articles Pages: 219 - 225
Amelioration of experimental lung metastasis in mice by therapy with anti-CD3 monoclonal antibodies David W. HoskinJana StankovaJohn C. Roder Original Articles Pages: 226 - 230
